Purav Vagadia is a skilled medicinal chemist with significant experience in both academic and industry settings. Currently serving as a lead chemist at Northwestern University, Purav Vagadia has successfully collaborated with a neuroscience professor at Duke University to enhance drug synthesis methods, thereby improving timelines for biological evaluation. Previous experience includes an MBA venture capital internship at Palo Santo, where responsibilities involved conducting due diligence and engaging in discussions with an IP lawyer to assess investment opportunities. Purav Vagadia has also contributed to GSK, focusing on chemical modifications and developing synthetic routes for important compounds. Educational qualifications include an MBA from Northwestern University's Kellogg School of Management, a Master of Science in Organic Chemistry from Villanova University, and a Bachelor of Science in Chemistry from Illinois Wesleyan University.